Next-Generation Drug Delivery Systems
This carefully selected group of stocks represents innovative companies revolutionizing how medications are delivered to patients. Handpicked by our professional analysts, these firms are developing technologies that make treatments simpler, more effective, and user-friendly, creating meaningful investment potential in an evolving healthcare landscape.
About This Group of Stocks
Our Expert Thinking
The FDA's approval of GSK's pre-filled Shingrix vaccine highlights a significant industry shift toward simplified drug delivery. Companies developing user-friendly delivery systems like pre-filled syringes, wearable pumps, and needle-free options are gaining valuable competitive advantages as pharmaceutical giants seek to differentiate their products.
What You Need to Know
This group includes companies across the drug delivery value chain, from oral alternatives to injectable medications to sustained-release implants. These innovations aim to reduce healthcare provider burden, minimize administration errors, and improve patient compliance, potentially leading to better clinical outcomes.
Why These Stocks
These companies were selected based on their position to benefit from the pharmaceutical industry's accelerating adoption of advanced delivery technologies. With proprietary platforms that transform complex treatments into simplified formats, they represent a tactical opportunity in response to recent regulatory validation.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock.
It only takes 60 seconds.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+374.90%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 374.9% over the next year.
Stocks Rated Buy by Analysts
13 of 15 assets in this group are rated Buy by professional analysts.
Why You'll Want to Watch These Stocks
Riding the Patient-First Healthcare Wave
Healthcare is rapidly shifting toward more patient-friendly treatments, and these companies are at the forefront. The FDA's recent approval of GSK's pre-filled Shingrix vaccine signals growing demand for simpler delivery solutions.
Pharmaceutical Giants Are Shopping
Major pharma companies are actively seeking innovative delivery systems to differentiate their products in crowded markets. This creates valuable partnership and acquisition opportunities for these specialized firms.
The Compliance Advantage
These technologies solve a critical healthcare challenge: patient compliance. By making treatments easier to administer correctly, these companies aren't just improving outcomes—they're creating potentially recurring revenue streams.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Unlock all the stocks in this group on Nemo
Sign up free to view all stocks in this group and never miss out on another investment opportunity with Nemo.
Sign up in 60 seconds
Zero commission trading
SIPC-protected up to $500,000
Backed by Exinity Group
6% AER interest on uninvested cash, paid out daily
AI investment insights
Discover More Opportunities
Streaming Profitability Revolution
Discover a carefully selected group of stocks positioned to benefit as streaming services shift from chasing subscribers to maximizing profits. These companies, handpicked by our analysts, represent the future of media as streaming platforms flex their pricing power and prioritize sustainable growth.
Streaming's Advertising-Powered Live Content Revolution
Netflix has proven that combining advertising, subscriptions, and live sports creates powerful growth. This carefully selected group of stocks represents companies positioned to benefit from this new streaming business model, from content providers to the ad tech making it all possible.
Social Media-Driven Short Squeeze Candidates
This collection features companies with high short interest that could potentially experience rapid price surges if targeted by retail investors on social media. Our analysts have carefully selected these stocks based on their similarity to recent phenomena like the Opendoor Technologies rally. These companies have the characteristics that often attract coordinated buying campaigns.
Frequently Asked Questions
Everything you need to know about the product and billing.
See the full stock group
Download Nemo to see all stocks in this group